526 related articles for article (PubMed ID: 16403469)
1. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.
Staub DR; Evans AK; Lowry CA
Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469
[TBL] [Abstract][Full Text] [Related]
2. Urocortin 2 increases c-Fos expression in topographically organized subpopulations of serotonergic neurons in the rat dorsal raphe nucleus.
Staub DR; Spiga F; Lowry CA
Brain Res; 2005 May; 1044(2):176-89. PubMed ID: 15885216
[TBL] [Abstract][Full Text] [Related]
3. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons.
Spiga F; Lightman SL; Shekhar A; Lowry CA
Neuroscience; 2006; 138(4):1265-76. PubMed ID: 16488545
[TBL] [Abstract][Full Text] [Related]
4. Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala.
Amat J; Tamblyn JP; Paul ED; Bland ST; Amat P; Foster AC; Watkins LR; Maier SF
Neuroscience; 2004; 129(3):509-19. PubMed ID: 15541873
[TBL] [Abstract][Full Text] [Related]
5. Acoustic stimulation in vivo and corticotropin-releasing factor in vitro increase tryptophan hydroxylase activity in the rat caudal dorsal raphe nucleus.
Evans AK; Heerkens JL; Lowry CA
Neurosci Lett; 2009 May; 455(1):36-41. PubMed ID: 19429102
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
7. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor (CRF) receptor subtypes in mediating neuronal activation of brain areas involved in responses to intracerebroventricular CRF and stress in rats.
Takahashi C; Ohata H; Shibasaki T
Peptides; 2011 Dec; 32(12):2384-93. PubMed ID: 21964377
[TBL] [Abstract][Full Text] [Related]
9. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
[TBL] [Abstract][Full Text] [Related]
10. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
[TBL] [Abstract][Full Text] [Related]
11. Functional CRF receptors in BON cells stimulate serotonin release.
von Mentzer B; Murata Y; Ahlstedt I; Lindström E; Martínez V
Biochem Pharmacol; 2007 Mar; 73(6):805-13. PubMed ID: 17184738
[TBL] [Abstract][Full Text] [Related]
12. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
Bittencourt JC; Vaughan J; Arias C; Rissman RA; Vale WW; Sawchenko PE
J Comp Neurol; 1999 Dec; 415(3):285-312. PubMed ID: 10553117
[TBL] [Abstract][Full Text] [Related]
13. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
[TBL] [Abstract][Full Text] [Related]
14. The effect of CRF2 receptor antagonists on rat conditioned fear responses and c-Fos and CRF expression in the brain limbic structures.
Skórzewska A; Lehner M; Hamed A; Wisłowska-Stanek A; Turzyńska D; Sobolewska A; Płaźnik A
Behav Brain Res; 2011 Aug; 221(1):155-65. PubMed ID: 21376756
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide has indomethacin-sensitive actions on Fos expression in topographically organized subpopulations of serotonergic neurons.
Hollis JH; Evans AK; Bruce KP; Lightman SL; Lowry CA
Brain Behav Immun; 2006 Nov; 20(6):569-77. PubMed ID: 16554144
[TBL] [Abstract][Full Text] [Related]
16. Urocortin 2 increases c-Fos expression in serotonergic neurons projecting to the ventricular/periventricular system.
Hale MW; Stamper CE; Staub DR; Lowry CA
Exp Neurol; 2010 Jul; 224(1):271-81. PubMed ID: 20382145
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
18. Urocortins and the regulation of gastrointestinal motor function and visceral pain.
Martinez V; Wang L; Million M; Rivier J; Taché Y
Peptides; 2004 Oct; 25(10):1733-44. PubMed ID: 15476940
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs.
Abrams JK; Johnson PL; Hay-Schmidt A; Mikkelsen JD; Shekhar A; Lowry CA
Neuroscience; 2005; 133(4):983-97. PubMed ID: 15916857
[TBL] [Abstract][Full Text] [Related]
20. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
